PURE Bioscience, Inc. (PURE) Operating margin 2017–2025
PURE Bioscience, Inc. (PURE) operating margin by fiscal year — reported operating income divided by reported revenue.
-103.2%FY2025 · since FY2017: -328.1% → -103.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -103.2% | +59.4 pp |
| FY2024 | -162.6% | +47.5 pp |
| FY2023 | -210.1% | -9.1 pp |
| FY2022 | -201.0% | -142.1 pp |
| FY2021 | -58.8% | -58.9 pp |
| FY2020 | 0.1% | +292.8 pp |
| FY2019 | -292.8% | +104.2 pp |
| FY2018 | -397.0% | -68.8 pp |
| FY2017 | -328.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice